fibrinogen has been researched along with Cardiometabolic Syndrome in 96 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 49 (51.04) | 29.6817 |
| 2010's | 43 (44.79) | 24.3611 |
| 2020's | 4 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Furr, M; Jayathilake, WMNK; Lacombe, VA; Risco, C | 1 |
| Harlow, SD; Karvonen-Gutierrez, CA; Lange-Maia, BS; Leis, AM; McConnell, DS; Sanders, WM; Ylitalo, KR | 1 |
| Božič Mijovski, M; Jug, B; Košuta, D; Novaković, M | 1 |
| Arietti, V; De Cecco, F; Liberale, C; Monzani, D; Nocini, R; Palma, S; Sacchetto, L; Segato, E | 1 |
| Guallar-Castillón, P; Gutierrez-Fisac, JL; Laclaustra, M; León-Muñoz, LM; Lopez-Garcia, E; Pérez-Tasigchana, RF; Rodríguez-Artalejo, F | 1 |
| Burguete-García, AI; Duggirala, R; León-Hernández, M; López-Alvarenga, JC; Moreno-Macías, H; Reding-Bernal, A; Sánchez-Pedraza, V; Serratos-Canales, MF; Sobrino-Cossio, S; Tejero-Barrera, ME | 1 |
| Abreu, S; Agostinis-Sobrinho, CA; Luís, L; Moreira, C; Mota, J; Oliveira-Santos, J; Ruiz, JR; Santos, R | 1 |
| Adebusuyi, JR; Adigun, K; Agbedana, EO; Ajobo, BM; Akinlade, KS; Arinola, OG; Charles-Davies, MA; Ebesunun, MO; Fabian, UA; Fasanmade, AA; Hassan, OO; Olaniyi, JA; Omiyale, W; Owolabi, MO; Oyewole, OE; Popoola, OO; Rahamon, SK | 1 |
| Bilić-Ćurčić, I; Franceschi, M; Jukić, T; Makarović, S; Mihaljević, I | 1 |
| Murtagh, EM; Rowe, DA; Stephens, JW; Thomas, NE; Williams, R | 1 |
| Colak, E; Dimitrijevic-Sreckovic, V; Gacic, J; Janeski, H; Janeski, N; Mrdovic, I; Soldatovic, I; Srećković, B; Sumarac-Dumanovic, M | 1 |
| Cendoroglo, M; Cendoroglo, MS; Dalboni, MA; Moreira, PF; Santos, GM | 1 |
| Bouglé, D; Brouard, J | 1 |
| Babić, D; Ljevak, I; Pavlović, M; Rastović, P | 1 |
| Biggs, ML; Britton, KA; Carnethon, M; Criqui, MH; Cushman, M; Djoussé, L; Garg, PK; Ix, JH; Mukamal, KJ; Newman, AB; Sutton-Tyrrell, K | 1 |
| Farid, E; Megahed, H; Saleh, N; Samir, N | 1 |
| Akcali, C; Buyukcelik, B; Inaloz, S; Kirtak, N | 1 |
| Bostan, C; Kaya, A; Ozkan, AA; Uzunhasan, I; Yigit, Z; Yildiz, A | 1 |
| Aryan, Z; Esteghamati, A; Nakhjavani, M | 1 |
| Grzebyk, E; Marciniak, D; Piwowar, A; Szymańska-Chabowska, A; Zurawska-Płaksej, E | 1 |
| Beckett, LA; Berglund, LF; Enkhmaa, B; Erdembileg, A; Mirsoian, A; Murphy, WJ; Zhang, W | 1 |
| DeStavola, B; Grundy, E; Ploubidis, GB; Silverwood, RJ | 1 |
| Akalin, N; Akay, H; Erturk, K; Harmankaya, O; Kaptanogullari, H; Kocoglu, H; Okuturlar, Y | 1 |
| Allison, M; Chan, C; Criqui, MH; Liu, K; McDermott, MM; Ouyang, P; Sibley, C; Szklo, M; Tracy, RP; Vidula, H | 1 |
| Adamovski, M; Bernal, RT; da Silva, NN; Debortoli, G; Gonçalves, Mde C; Mastroeni, MF; Mastroeni, SS; Rondó, PH; Veugelers, PJ | 1 |
| Gao, BL; Su, BY; Tian, CF; Tong, YH; Zhao, XH; Zheng, Y | 1 |
| Chu, MC; Cushman, M; Lobo, RA; Solomon, R | 1 |
| Albayrak, S; Can, G; Erbilen, E; Hergenç, G; Keleş, I; Küçükdurmaz, Z; Onat, A; Ozhan, H | 1 |
| Berliner, S; Rogowski, O; Shapira, I | 1 |
| Beilby, JP; Carter, KW; Foo, BT; Hung, J; Jennens, M; Leow, YC; McCaskie, PA; McQuillan, BM; Palmer, LJ; Powell, BL; Thompson, PL; Wiltshire, S | 1 |
| Rosenson, RS | 1 |
| Alonso, I; Ayala, DE; Chayán, L; Domínguez, MJ; Fernández, JR; Fontao, MJ; Hermida, RC; Mojón, A; Soler, R | 1 |
| Cushman, M; Folsom, AR; Heckbert, SR; Jacobs, DR; Peacock, JM; Rosamond, WD; Steffen, LM | 1 |
| Bouskela, E; Kraemer-Aguiar, LG; Lima, LM; Wiernsperger, N | 1 |
| Holz, O; Kirsten, A; Kretschmar, G; Magnussen, H; Meyer, T; Müller, KC; Waschki, B; Watz, H | 1 |
| Ferdinand, KC; Morris, A | 1 |
| Dzanković, F; Macić-Dzanković, A; Pojskić, B; Velija-Asimi, Z | 1 |
| Balagopal, P; Bird, K; Damaso, L; Delgiorno, C; Kollman, C; Mauras, N; Morgan, M; Sweeten, S | 1 |
| Ge, Y; Wang, X; Xu, M; Yan, Y; Yao, R | 1 |
| Anghelescu, I; Heuser, I; Quante, A; Schwarzer, R; Zeugmann, S | 1 |
| Alioglu, E; Asgun, F; Ercan, E; Kirilmaz, B; Ozerkan, F; Saygi, S; Tengiz, I; Turk, U | 1 |
| Cheung, BM; Jiang, CQ; Jin, YL; Lam, TH; Lin, JM; Liu, B; Thomas, GN; Yue, XJ | 1 |
| Bi, Z; Dong, J; Fu, Z; Guo, X; Jia, C; Liu, L; Ma, J; Su, J; Xu, A | 1 |
| Antonini-Canterin, F; Balbarini, A; Benedetto, F; Carerj, S; Di Bello, V; Di Salvo, G; Gullace, G; La Carrubba, S; Novo, S; Perticone, F; Pezzano, A; Zito, C | 1 |
| Abdel Gader, AG; Awadallah, SB; Habib, F; Khashoggi, TY | 1 |
| Bachowski, R; Gdula-Dymek, A; Krysiak, R; Okopien, B | 1 |
| Fritsch, M; Fritsch, P; Kleber, M; Mangge, H; Muntean, W; Reinehr, T; Rosenkranz, A | 1 |
| Chen, J; Cui, X; Fang, D | 1 |
| Chen, JY; Luo, BJ; Tan, N; Yu, DQ; Zhou, YL | 1 |
| Beavers, KM; Nicklas, BJ | 1 |
| Chiotinis, N; Diamantopoulos, E; Goumas, G; Kapsokefalou, M; Koutelidakis, AE; Pounis, GD; Richter, DJ; Sialvera, TE; Yfanti, G; Zampelas, A | 1 |
| Baelum, V; Casanova, PA; Ibieta, CI; López, NJ; López, R; Quintero, A | 1 |
| Bonet, E; Corella, D; Hernández-Mijares, A; Laiz, B; Pérez, R; Sendra, R; Solá, E; Vayá, A | 1 |
| Barac, A; Best, LG; Carter, EA; de Simone, G; Devereux, RB; Dixon, DB; Howard, BV; Panza, JA; Shara, NM; Umans, JG; Wang, H; Yeh, J | 1 |
| Abbasi, F; Malhotra, D; Mathur, A; Molina, CR; Reaven, GM | 1 |
| Anghelescu, I; Heuser, I; Kössler, W; Popova-Zeugmann, L; Quante, A; Zeugmann, S | 1 |
| Bitter, H; Cheng, DT; Cockayne, DA; Fine, JS; Hilton, H; Holz, O; Kourteva, G; Magnussen, H; Müller, KC; Pillai, SG; Ravindran, P; Sridhar, S; Visvanathan, S; Waschki, B; Watz, H | 1 |
| Countryman, AJ; Llabre, MM; McCalla, JR; Penedo, FJ; Saab, PG; Schneiderman, N | 1 |
| Catto, AJ; Grant, PJ; Lansbury, AJ | 1 |
| Bermudo, F; Ceballos, P; Gascón, F; Martos, R; Suanes, A; Valle, M | 1 |
| Cevik, C; Göldeli, E; Güneri, S; Savaş, S; Soysal, D; Sözmen, E; Susam, I | 1 |
| Tracy, RP | 1 |
| Ford, ES | 1 |
| Angeloni, SV; Hansen, BC; Selaru, IK; Tigno, XT | 1 |
| Berg, C; Herrmann, BL; Mann, K; Nowak, T; Renzing-Koehler, K; Saller, B; Vogel, E | 1 |
| Alessi, MC; Juhan-Vague, I; Morange, PE | 1 |
| Can, G; Hergenç, G; Onat, A; Sansoy, V; Sari, I; Uyarel, H; Uzunlar, B; Yazici, M | 1 |
| Crook, D; Godsland, IF; Proudler, AJ; Stevenson, JC | 1 |
| Cañete, R; Gascón, F; Martos, R; Morales, R; Valle, M; Zafra, MA | 1 |
| Ciccarelli, L; Cicero, AF; Derosa, G; Ferrari, I; Gaddi, AV; Ghelfi, M; Peros, E; Piccinni, MN; Salvadeo, S | 1 |
| Elisaf, MS; Goudevenos, J; Mikhailidis, DP; Milionis, HJ; Rizos, E; Seferiadis, K | 1 |
| Athyros, VG; Elisaf, M; Mikhailidis, DP | 1 |
| Bertolini, L; Falezza, G; Scala, L; Targher, G; Zenari, L; Zoppini, G | 1 |
| Mertens, I; Michiels, JJ; Ruige, JB; Van der Planken, M; Van Gaal, LF; Verrijken, A | 1 |
| Kurl, S; Laaksonen, D; Laukkanen, JA; Niskanen, L; Nyyssönen, K; Salonen, JT; Sivenius, J | 1 |
| Mertens, I; Van Gaal, LF | 1 |
| Marie, B; Maumus, S; Siest, G; Vincent-Viry, M; Visvikis-Siest, S | 1 |
| Benzi, L; Cuccuru, I; Del Prato, S; Di Cianni, G; Ghio, A; Lencioni, C; Miccoli, R; Pellegrini, G; Volpe, L | 1 |
| Fries, D; Greie, S; Gunga, HC; Hoertnagl, H; Hoffmann, G; Humpeler, E; Klingler, A; Koralewski, E; Lechleitner, M; Mittermayr, M; Schobersberger, W; Strauss-Blasche, G | 1 |
| Freed, MI; Haffner, SM; Herman, WH; Holman, RR; Jones, NP; Kahn, SE; Kravitz, BG; Lachin, JM; O'Neill, MC; Viberti, GC; Yu, D; Zinman, B | 1 |
| Dimcevski, G; Holm, J; Montvilas, P; Mouritsen, E; Suciu, G; von Eyben, FE | 1 |
| Bielak, LF; Coutinho, Tde A; Kullo, IJ; Peyser, PA; Sheedy, PF; Turner, ST | 1 |
| Baptista, T; Beaulieu, S; Contreras, Q; de Mendoza, S; Galeazzi, T; Lacruz, A; Rangel, N; Sandia, I; Vargas, D | 1 |
| Beddhu, S; Cheung, AK; Murtaugh, MA; Ramkumar, N | 1 |
| Ay, C; Dorda, W; Pabinger, I; Simanek, R; Tengler, T; Vormittag, R; Vukovich, T | 1 |
| Boreham, CA; Ferreira, I; Gallagher, AM; Murray, LJ; Stehouwer, CD; Twisk, JW; Young, IS | 1 |
| Barontini, R; Bianchi, C; Corfini, M; Del Prato, S; Di Cianni, G; Giovannitti, MG; Malloggi, L; Miccoli, R; Penno, G | 1 |
| Avdagić, N; Fajkić, A; Lepara, O; Nakag-Ićindić, E; Valjevac, A | 1 |
| Carter, AM; Cymbalista, CM; Grant, PJ; Spector, TD | 1 |
| Alizadeh Dehnavi, R; Beishuizen, ED; Huisman, MV; Kluft, C; Le Cessie, S; Princen, HM; Tamsma, JT; van de Ree, MA | 1 |
| Aparci, M; Cebeci, BS; Cingozbay, BY; Inanc, T; Kardesoglu, E; Ozcelik, F; Ozmen, N; Sener, G; Suleymanoglu, S; Yiginer, O | 1 |
| Atalar, E; Beyazit, Y; Guven, GS; Haznedaroglu, IC; Kekilli, M; Kilicarslan, A; Oz, G; Ozer, N; Sahiner, L; Sozen, T; Yavuz, B | 1 |
| Bub, A; Hahn, A; Hülsmann, O; Kressel, G; Lichtinghagen, R; Stichtenoth, DO; Trunz, B; Wolters, M | 1 |
| Alfenas, Rde C; Bressan, J; Costa, NM; Minim, VP; Stringueta, PC; Volp, AC | 1 |
| Blair, SN; Church, TS; Earnest, CP; Finley, CE; Gibbons, LW; Kampert, JB | 1 |
| Bergmann, S; Hanefeld, M; Henkel, E; Jaross, W; Koehler, C; Siegert, G; Temelkova-Kurktschiev, T | 1 |
5 review(s) available for fibrinogen and Cardiometabolic Syndrome
| Article | Year |
|---|---|
The Role of Fibrinogen, Homocysteine and Metabolic Syndrome's Alterations in Sudden Sensorineural Hearing Loss (SSHL): A Narrative Review.
Topics: Fibrinogen; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Homocysteine; Humans; Metabolic Syndrome | 2023 |
Effects of lifestyle interventions on inflammatory markers in the metabolic syndrome.
Topics: Biomarkers; C-Reactive Protein; Cytokines; Fibrinogen; Humans; Inflammation; Leukocyte Count; Metabolic Syndrome; Prevalence; Risk Reduction Behavior | 2011 |
Inflammation, the metabolic syndrome and cardiovascular risk.
Topics: Arteriosclerosis; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Estrogens; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Metabolic Syndrome; Risk Factors | 2003 |
Relations between hemostatic variables, insulin resistance and inflammation.
Topics: Adipose Tissue; Adult; Aged; C-Reactive Protein; Cohort Studies; Cytokines; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Inflammation; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Thrombophilia; von Willebrand Factor | 2004 |
[Inflammation biomarkers capacity in predicting the metabolic syndrome].
Topics: Adipokines; Biomarkers; C-Reactive Protein; Chemokines; Cytokines; Fibrinogen; Humans; Inflammation Mediators; Insulin Resistance; Metabolic Syndrome; Obesity; Predictive Value of Tests; Serum Amyloid A Protein | 2008 |
15 trial(s) available for fibrinogen and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antithrombins; Biomarkers; Blood Coagulation; C-Reactive Protein; Chemokine CCL2; E-Selectin; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Interleukin-6; Matrix Metalloproteinase 9; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Tissue Inhibitor of Metalloproteinase-1 | 2008 |
Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients.
Topics: Adiponectin; Adult; Aged; Biomarkers; C-Reactive Protein; Chemokine CCL2; Chemokine CCL3; Female; Fenofibrate; Fibrinogen; Humans; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Interleukin-1beta; Male; Metabolic Syndrome; Middle Aged; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2009 |
Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Humans; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Middle Aged; Pedigree; Risk Factors; Statistics, Nonparametric | 2009 |
Evaluation of risk markers fluctuation during an initial therapy with rosiglitazon in patients suffering from metabolic syndrome.
Topics: Biomarkers; C-Reactive Protein; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Longitudinal Studies; Male; Metabolic Syndrome; Risk Factors; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Uric Acid | 2009 |
Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes.
Topics: Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Cytokines; Factor VII; Fenofibrate; Fibrinogen; Heptanoic Acids; Humans; Metabolic Syndrome; Plasminogen Activator Inhibitor 1; Prediabetic State; Pyrroles | 2010 |
Phytosterols supplementation decreases plasma small and dense LDL levels in metabolic syndrome patients on a westernized type diet.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoprotein A-I; Arterial Pressure; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diet; Diet Records; Dietary Supplements; Energy Intake; Female; Fibrinogen; Humans; Male; Metabolic Syndrome; Middle Aged; Phytosterols; Risk Factors; Single-Blind Method; Triglycerides; Yogurt | 2012 |
Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a controlled clinical trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atherosclerosis; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol; Dental Plaque; Dental Scaling; Double-Blind Method; Female; Fibrinogen; Follow-Up Studies; Humans; Lipoproteins; Male; Metabolic Syndrome; Metronidazole; Middle Aged; Obesity; Periodontitis; Placebos; Risk Factors; Root Planing | 2012 |
Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.
Topics: Aged; Arginine; Blood Glucose; Blood Pressure; Body Composition; Body Constitution; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Lipids; Male; Metabolic Syndrome; Metformin; Middle Aged; Obesity; Placebos; Testosterone | 2004 |
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Tissue Plasminogen Activator | 2005 |
Inflammatory markers and the metabolic syndrome.
Topics: Antihypertensive Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Fenofibrate; Fibrinogen; Heptanoic Acids; Humans; Hypolipidemic Agents; Inflammation; Lactones; Leukocyte Count; Metabolic Syndrome; Metformin; Orlistat; Prospective Studies; Pyrroles; Treatment Outcome | 2005 |
Improvement of metabolic syndrome markers through altitude specific hiking vacations.
Topics: Adult; Aged; Altitude; Blood Glucose; Blood Pressure; Body Composition; Cholesterol; Exercise Test; Fibrinogen; Humans; Insulin; Leisure Activities; Male; Metabolic Syndrome; Middle Aged; Triglycerides; Walking | 2006 |
Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; C-Reactive Protein; Double-Blind Method; Female; Fibrinogen; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Metformin; Middle Aged; Olanzapine; Schizophrenia; Sex Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome.
Topics: Aged; Allopurinol; Blood Flow Velocity; Brachial Artery; C-Reactive Protein; Double-Blind Method; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Follow-Up Studies; Free Radical Scavengers; Humans; Male; Metabolic Syndrome; Middle Aged; Oxidative Stress; Peroxidase; Spectrophotometry; Treatment Outcome; Ultrasonography; Vasodilation | 2008 |
Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndrome.
Topics: Adult; Carboxypeptidase B2; Endothelium, Vascular; Female; Fenofibrate; Fibrinogen; Humans; Hypolipidemic Agents; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Pulsatile Flow; Vasodilation | 2008 |
Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.
Topics: Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; C-Reactive Protein; Causality; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Leukocyte Count; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Risk Factors | 2002 |
76 other study(ies) available for fibrinogen and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Equine insulin dysregulation causes tissue specific alterations of proinflammatory cytokines and acute phase proteins in a NF-kB independent manner.
Topics: Acute-Phase Proteins; Adipose Tissue; Animals; Cytokines; Fibrinogen; Horse Diseases; Horses; Humans; Insulin; Insulin Resistance; Interleukin-6; Metabolic Syndrome; NF-kappa B | 2022 |
The Association of Inflammatory Factors With Peripheral Neuropathy: The Study of Women's Health Across the Nation.
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Female; Fibrinogen; Humans; Inflammation; Metabolic Syndrome; Middle Aged; Obesity; Peripheral Nervous System Diseases; Risk Factors; Women's Health | 2023 |
The Correlation between the Triglyceride-Glucose Index and Coagulation Markers in Patients with Recent Acute Myocardial Infarction.
Topics: Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Female; Fibrinogen; Glucose; Hemostatics; Humans; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Risk Assessment; Risk Factors; Thrombophilia; Triglycerides | 2022 |
Metabolic syndrome and insulin resistance are associated with frailty in older adults: a prospective cohort study.
Topics: Age Factors; Aged; Aging; Biomarkers; Blood Coagulation; Blood Glucose; C-Reactive Protein; Female; Fibrinogen; Frail Elderly; Frailty; Geriatric Assessment; Humans; Incidence; Inflammation Mediators; Insulin; Insulin Resistance; Logistic Models; Male; Metabolic Syndrome; Middle Aged; Odds Ratio; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Spain; Time Factors | 2017 |
Heritability and genetic correlation between GERD symptoms severity, metabolic syndrome, and inflammation markers in families living in Mexico City.
Topics: Adult; Blood Glucose; Body Mass Index; C-Reactive Protein; Cross-Sectional Studies; Fasting; Female; Fibrinogen; Gastroesophageal Reflux; Heredity; Humans; Inflammation; Male; Metabolic Syndrome; Mexico; Middle Aged; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires | 2017 |
Cardiorespiratory fitness and inflammatory profile on cardiometabolic risk in adolescents from the LabMed Physical Activity Study.
Topics: Adolescent; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiorespiratory Fitness; Cholesterol; Complement C3; Complement C4; Exercise; Female; Fibrinogen; Humans; Leptin; Male; Metabolic Syndrome; Triglycerides; Waist Circumference | 2017 |
Changes in mediators of inflammation and pro-thrombosis after 12 months of dietary modification in adults with metabolic syndrome.
Topics: Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Diet; Female; Fibrinogen; Humans; Inflammation; Interleukin-10; Interleukin-6; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Nigeria; Plasminogen Activator Inhibitor 1; Thrombosis; Triglycerides; Waist Circumference | 2017 |
Bone Mineral Density in Relation to Metabolic Syndrome Components in Postmenopausal Women With Diabetes Mellitus Type 2
Topics: Aged; Biomarkers; Body Mass Index; Bone Density; C-Reactive Protein; Collagen; Diabetes Mellitus, Type 2; Female; Femur; Fibrinogen; Glycated Hemoglobin; Humans; Hyperinsulinism; Insulin; Metabolic Syndrome; Middle Aged; Obesity; Obesity, Abdominal; Osteocalcin; Osteoporosis, Postmenopausal; Peptide Fragments; Plasminogen Activator Inhibitor 1; Postmenopause; Spine; Waist Circumference | 2017 |
Associations between metabolic syndrome components and markers of inflammation in Welsh school children.
Topics: Adolescent; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Child; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Male; Metabolic Syndrome; Multivariate Analysis; Risk Assessment; Risk Factors; Waist Circumference; Wales | 2018 |
Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score.
Topics: Adult; Age Factors; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Confounding Factors, Epidemiologic; Cross-Sectional Studies; Decision Support Techniques; Dyslipidemias; Female; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation Mediators; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Obesity, Abdominal; Predictive Value of Tests; Risk Factors; Up-Regulation; Uric Acid | 2018 |
Postprandial interleukin-6 response in elderly with abdominal obesity and metabolic syndrome.
Topics: Aged; Anthropometry; Area Under Curve; Blood Glucose; Blood Pressure; Brazil; C-Reactive Protein; Cholesterol; Female; Fibrinogen; Humans; Interleukin-6; Male; Metabolic Syndrome; Obesity, Abdominal; Postprandial Period; Triglycerides; Tumor Necrosis Factor-alpha | 2013 |
Iron in child obesity. Relationships with inflammation and metabolic risk factors.
Topics: Adolescent; Blood Pressure; Body Mass Index; Child; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Fatty Liver; Female; Ferritins; Fibrinogen; Humans; Inflammation; Iron; Liver; Male; Metabolic Syndrome; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Pediatric Obesity; Regression Analysis; Risk Factors; Transaminases; Triglycerides | 2013 |
Association of erythrocyte sedimentation rate and fibrinogen concentration with metabolic syndrome in schizophrenic patients.
Topics: Adolescent; Adult; Aged; Blood Sedimentation; Comorbidity; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Schizophrenia; Young Adult | 2013 |
Metabolic syndrome and risk of incident peripheral artery disease: the cardiovascular health study.
Topics: Aged; Ankle Brachial Index; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Metabolic Syndrome; Peripheral Arterial Disease; Prevalence; Risk Factors; Vasculitis | 2014 |
Homocysteine and other cardiovascular risk factors in patients with lichen planus.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Dyslipidemias; Female; Fibrinogen; Homocysteine; Humans; Lichen Planus; Male; Metabolic Syndrome; Middle Aged; Risk Factors | 2014 |
Clinical and laboratory parameters associated with metabolic syndrome in Turkish patients with psoriasis.
Topics: Adiponectin; Adult; Body Mass Index; Cardiovascular Diseases; Female; Fibrinogen; Humans; Hyperglycemia; Hypertriglyceridemia; Lipoproteins, HDL; Male; Metabolic Syndrome; Obesity; Psoriasis; Triglycerides; Turkey | 2014 |
Beneficial effects of rosuvastatin treatment in patients with metabolic syndrome.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Fluorobenzenes; Glycated Hemoglobin; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Lipids; Male; Metabolic Syndrome; Middle Aged; Oxidative Stress; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome | 2015 |
Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: associations with inflammatory and cardiometabolic markers in 4391 subjects.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Inflammation; Insulin Resistance; Iran; Lipids; Liver; Male; Metabolic Syndrome; Middle Aged; Obesity; Vitamin D; Waist Circumference | 2014 |
Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome.
Topics: Adult; Advanced Oxidation Protein Products; Aged; Biomarkers; Blood Glucose; Female; Fibrinogen; Humans; Male; Metabolic Syndrome; Middle Aged; Oxidative Stress; Risk Factors; Serum Albumin; Serum Albumin, Human | 2014 |
Attenuated age-impact on systemic inflammatory markers in the presence of a metabolic burden.
Topics: Age Factors; Animals; Biomarkers; Black or African American; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Male; Metabolic Syndrome; Mice; Middle Aged; Risk Factors; Serum Amyloid A Protein; White People | 2015 |
Life-Course Partnership Status and Biomarkers in Midlife: Evidence From the 1958 British Birth Cohort.
Topics: Adult; Age Factors; Biomarkers; C-Reactive Protein; Cohort Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Health Status; Humans; Male; Marital Status; Metabolic Syndrome; Middle Aged; Sex Factors; Single Person; Tissue Plasminogen Activator; United Kingdom; Vital Capacity; von Willebrand Factor; Young Adult | 2015 |
Comparison of risk factors for cardiovascular disease in hemodialysis and peritoneal dialysis patients.
Topics: Adult; Atherosclerosis; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Peritoneal Dialysis; Renal Dialysis; Risk Factors; Triglycerides | 2015 |
Metabolic syndrome and incident peripheral artery disease - the Multi-Ethnic Study of Atherosclerosis.
Topics: Aged; Aged, 80 and over; Ankle Brachial Index; Atherosclerosis; Biomarkers; Blood Glucose; C-Reactive Protein; Cholesterol, LDL; Cohort Studies; Creatinine; Ethnicity; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Peripheral Arterial Disease | 2015 |
Cardiometabolic risk markers of normal weight and excess body weight in Brazilian adolescents.
Topics: Adolescent; Biomarkers; Blood Glucose; Blood Pressure; Body Weight; Brazil; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Exercise; Female; Fibrinogen; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Logistic Models; Male; Metabolic Syndrome; Overweight; Risk Factors; Socioeconomic Factors; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |
Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; China; Female; Fibrinogen; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Leukocyte Count; Lipids; Male; Metabolic Syndrome; Middle Aged; Obesity; Prevalence; Transaminases; Uric Acid | 2016 |
Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels.
Topics: Adult; Blood Pressure; C-Reactive Protein; Female; Fibrinogen; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Obesity; Predictive Value of Tests; Prospective Studies; Risk Factors; Sex Distribution; Smoking; Turkey | 2009 |
Exploring the usefulness of inflammation-sensitive biomarkers to reveal potential sex differences in relation to low-grade inflammation in individuals with the metabolic syndrome.
Topics: Aged; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Metabolic Syndrome; Middle Aged; Neutrophils; Severity of Illness Index; Sex Characteristics | 2008 |
Association of Interleukin-1 gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population.
Topics: Adult; Alleles; Body Mass Index; Coronary Disease; Female; Fibrinogen; Genotype; Humans; Inflammation; Interleukin-1; Male; Metabolic Syndrome; Middle Aged; Obesity; Polymorphism, Single Nucleotide | 2008 |
Association of metabolic syndrome and blood pressure nondipping profile in untreated hypertension.
Topics: Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Creatine; Cross-Sectional Studies; Female; Fibrinogen; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Logistic Models; Male; Metabolic Syndrome; Middle Aged; Motor Activity; Smoking; Uric Acid | 2009 |
Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology.
Topics: Blood Coagulation Factors; Blood Glucose; Blood Pressure; Body Mass Index; Cohort Studies; Female; Fibrinogen; Humans; Lipids; Longitudinal Studies; Male; Metabolic Syndrome; Proportional Hazards Models; Risk Factors; Venous Thromboembolism | 2009 |
The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity.
Topics: Aged; Biomarkers; Bronchitis; C-Reactive Protein; Chronic Disease; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Motor Activity; Pulmonary Disease, Chronic Obstructive; Regression Analysis | 2009 |
Patients with hypertension and the cardiometabolic syndrome: the potential impact of inflammatory biomarkers.
Topics: Biomarkers; Black or African American; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Hypertension; Inflammation; Interleukin-6; Metabolic Syndrome; Middle Aged; Risk Factors; Tumor Necrosis Factor-alpha | 2009 |
Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children.
Topics: Absorptiometry, Photon; Adolescent; Analysis of Variance; Body Composition; Body Mass Index; C-Reactive Protein; Carbohydrate Metabolism; Child; Dyslipidemias; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Glucose Intolerance; Humans; Hypertension; Inflammation; Interleukin-6; Male; Metabolic Syndrome; Obesity; Plasminogen Activator Inhibitor 1; Puberty; Risk Factors; Sex Factors; Waist Circumference | 2010 |
An cell-assembly derived physiological 3D model of the metabolic syndrome, based on adipose-derived stromal cells and a gelatin/alginate/fibrinogen matrix.
Topics: Adipocytes; Adipogenesis; Adipokines; Adipose Tissue; Alginates; Animals; Endothelin-1; Endothelium; Fatty Acids, Nonesterified; Fibrinogen; Gelatin; Glucose; Glucuronic Acid; Hexuronic Acids; Insulin; Insulin Secretion; Lipid Metabolism; Metabolic Syndrome; Microscopy, Electron, Scanning; Models, Biological; Nitric Oxide; Rats; Rats, Sprague-Dawley; Stromal Cells; Tissue Scaffolds | 2010 |
Inflammatory biomarkers in 70 depressed inpatients with and without the metabolic syndrome.
Topics: Adiponectin; Biomarkers; C-Reactive Protein; CD40 Ligand; Comorbidity; Depressive Disorder, Major; E-Selectin; Female; Fibrinogen; Hospitalization; Humans; Inflammation; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Resistin; Tumor Necrosis Factor-alpha | 2010 |
High inflammatory activity related to the number of metabolic syndrome components.
Topics: Blood Cell Count; Body Mass Index; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Humans; Hypertension; Inflammation; Interleukin-6; Logistic Models; Male; Metabolic Syndrome; Middle Aged; Models, Biological; Risk Factors; Statistics as Topic; Ultrasonography; Uric Acid | 2010 |
Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD.
Topics: Aged; Alleles; Blood Glucose; C-Reactive Protein; Female; Fibrinogen; Genetics, Population; Genotype; Humans; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Polymorphism, Single Nucleotide; Prevalence; Receptors, Interleukin-6; Risk Factors; Triglycerides | 2010 |
Associations of fibrinogen with metabolic syndrome in rural Chinese population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; China; Female; Fibrinogen; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Regression Analysis; Rural Population; Young Adult | 2010 |
Association between carotid atherosclerosis and metabolic syndrome: results from the ISMIR study.
Topics: Aged; Blood Glucose; Carotid Artery Diseases; Creatinine; Cross-Sectional Studies; Female; Fibrinogen; Humans; Italy; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Triglycerides; Tunica Intima; Tunica Media; Uric Acid | 2010 |
Haemostatic and cytokine changes in gestational diabetes mellitus.
Topics: Adult; Antithrombins; Body Mass Index; Cross-Sectional Studies; Diabetes, Gestational; Female; Fibrinogen; Hemostasis; Humans; Interleukins; Metabolic Syndrome; Pregnancy; Pregnancy Trimester, Third; Protein C; Protein S | 2011 |
Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation, and fibrinogen levels.
Topics: Adolescent; Blood Pressure; Body Weight; Child; Female; Fibrinogen; Hemostasis; Humans; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Obesity; Overweight; Prospective Studies; Thrombin | 2010 |
Bioinformatic analyses and an expression study of a novel gene associated with metabolic syndrome.
Topics: Amino Acid Sequence; Cell Line, Tumor; Chromosomes, Human, Pair 10; Computational Biology; DNA, Complementary; Dose-Response Relationship, Drug; Fibrinogen; Gene Expression; Glucose; Humans; Liver; Mannitol; Metabolic Syndrome; Molecular Sequence Data; Neoplasm Proteins; Open Reading Frames; Peptide Fragments; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, Protein; Sequence Homology, Amino Acid | 2010 |
[Correlation of microalbuminuria and fibrinogen to the severity of coronary artery lesions in patients with metabolic syndrome].
Topics: Aged; Albuminuria; Coronary Artery Disease; Female; Fibrinogen; Humans; Male; Metabolic Syndrome; Middle Aged | 2010 |
Association between hemorheological alterations and metabolic syndrome.
Topics: Adult; Aged; Blood Cell Count; Blood Glucose; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cholesterol; Erythrocyte Indices; Female; Fibrinogen; Glycated Hemoglobin; Hemorheology; Humans; Insulin; Male; Metabolic Syndrome; Middle Aged; Triglycerides; Waist-Hip Ratio | 2011 |
Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart Study.
Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus; Female; Fibrinogen; Health Surveys; Heart Failure; Humans; Indians, North American; Inflammation; Male; Metabolic Syndrome; Middle Aged; Obesity; Prevalence; Proportional Hazards Models; Risk Factors; United States | 2012 |
Body mass index and waist circumference associate to a comparable degree with insulin resistance and related metabolic abnormalities in South Asian women and men.
Topics: Adiposity; Adult; Asia, Southeastern; Asian People; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; California; Cross-Sectional Studies; Dyslipidemias; Female; Fibrinogen; Humans; Hypertension; Insulin; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Obesity; Sex Factors; Waist Circumference | 2012 |
Pathways linking early life stress, metabolic syndrome, and the inflammatory marker fibrinogen in depressed inpatients.
Topics: Adult; Aged; Child; Child Abuse; Depressive Disorder, Major; Endophenotypes; Female; Fibrinogen; Humans; Inflammation Mediators; Life Change Events; Male; Metabolic Syndrome; Middle Aged; Models, Statistical; Risk Factors | 2012 |
Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity.
Topics: Acute-Phase Proteins; Aged; Biomarkers; Cohort Studies; Comorbidity; Female; Fibrinogen; Forced Expiratory Volume; Granulocyte Colony-Stimulating Factor; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-3; Lipocalin-2; Lipocalins; Male; Metabolic Syndrome; Multivariate Analysis; Proto-Oncogene Proteins; Pulmonary Diffusing Capacity; Pulmonary Disease, Chronic Obstructive; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Recombinant Fusion Proteins; Regression Analysis; S100 Proteins; S100A12 Protein; Smoking; Transforming Growth Factor alpha | 2012 |
Cardiometabolic risk in adolescents: associations with physical activity, fitness, and sleep.
Topics: Adolescent; Adolescent Behavior; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Depression; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Metabolic Syndrome; Models, Psychological; Motor Activity; Physical Fitness; Psychiatric Status Rating Scales; Risk Factors; Sleep Initiation and Maintenance Disorders | 2013 |
Atherothrombotic risk factors in subjects with a family history of stroke.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Male; Medical Records; Metabolic Syndrome; Middle Aged; Risk Factors; Stroke; Thrombosis; von Willebrand Factor | 2002 |
Relationship between high plasma leptin concentrations and metabolic syndrome in obese pre-pubertal children.
Topics: Body Mass Index; Child; Cross-Sectional Studies; Female; Fibrinogen; Humans; Insulin; Leptin; Male; Metabolic Syndrome; Obesity; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 2003 |
The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome x and healthy subjects.
Topics: Adult; Aged; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Female; Fibrinogen; Homocysteine; Humans; Linear Models; Male; Metabolic Syndrome; Middle Aged; Nitrites; Odds Ratio; Risk Factors; Triglycerides; Turkey | 2003 |
The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey.
Topics: Adult; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Metabolic Syndrome; Middle Aged; Nutrition Surveys; Odds Ratio; Osmolar Concentration; United States | 2003 |
Is microvascular flow rate related to ghrelin, leptin and adiponectin levels?
Topics: Adiponectin; Animals; Blood Glucose; Fibrinogen; Ghrelin; Hyperglycemia; Hyperinsulinism; Hypertriglyceridemia; Hypolipidemic Agents; Intercellular Signaling Peptides and Proteins; Leptin; Macaca mulatta; Metabolic Syndrome; Microcirculation; Obesity; Peptide Hormones; Prediabetic State; Proteins | 2003 |
Cross-sectional study of complement C3 as a coronary risk factor among men and women.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cholesterol; Cohort Studies; Complement C3; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Insulin; Male; Metabolic Syndrome; Middle Aged; Obesity; Odds Ratio; Risk Factors; Smoking; Triglycerides | 2005 |
Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome.
Topics: Adipose Tissue; Adult; Aged; Body Composition; Body Mass Index; Cholesterol, LDL; Factor X; Fibrinogen; gamma-Glutamyltransferase; Hemostasis; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Smoking | 2005 |
Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome.
Topics: Adiponectin; Blood Glucose; Blood Pressure; C-Reactive Protein; Child; Cross-Sectional Studies; Female; Fibrinogen; Homeostasis; Humans; Inflammation; Insulin; Intercellular Signaling Peptides and Proteins; Leptin; Lipids; Male; Metabolic Syndrome; Obesity; Plasminogen Activator Inhibitor 1 | 2005 |
Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects.
Topics: Aged; Apolipoprotein A-I; Brain Ischemia; Case-Control Studies; Cholesterol; Cholesterol, HDL; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Ischemia; Lipoprotein(a); Lipoproteins, HDL; Logistic Models; Male; Metabolic Syndrome; Obesity; Odds Ratio; Regression Analysis; Risk Factors; Stroke; Triglycerides; Uric Acid | 2005 |
Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.
Topics: Adipose Tissue; Adult; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Endothelium; Fatty Liver; Fibrinogen; Humans; Inflammation; Insulin Resistance; Male; Metabolic Syndrome; Plasminogen Activator Inhibitor 1; Tomography, X-Ray Computed; Triglycerides; von Willebrand Factor | 2005 |
Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Metabolic Syndrome; Obesity; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; von Willebrand Factor; Waist-Hip Ratio; World Health Organization | 2006 |
Metabolic syndrome and the risk of stroke in middle-aged men.
Topics: Adult; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Diabetes Complications; Fibrinogen; Finland; Follow-Up Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Risk; Risk Factors; Smoking; Stroke; Time Factors | 2006 |
New International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment panel III (NCEP-ATPIII) criteria and the involvement of hemostasis and fibrinolysis in the metabolic syndrome.
Topics: Adult; Case-Control Studies; Cholesterol; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Metabolic Syndrome; Obesity; Overweight; Patient Education as Topic; Plasminogen Activator Inhibitor 1; Societies; von Willebrand Factor | 2006 |
Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB-455 G/A polymorphism.
Topics: Adenine; Adult; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Fasting; Female; Fibrinogen; France; Gene Frequency; Genetic Predisposition to Disease; Genotype; Guanine; Homeostasis; Humans; Immunoenzyme Techniques; Insulin; Male; Metabolic Syndrome; Middle Aged; Polymorphism, Single Nucleotide; Reference Values; Risk Factors | 2007 |
C-reactive protein and metabolic syndrome in women with previous gestational diabetes.
Topics: Abdomen; Adult; C-Reactive Protein; Diabetes, Gestational; Female; Fibrinogen; Homocysteine; Humans; Hyperglycemia; Lipoproteins, HDL; Metabolic Syndrome; Obesity; Parity; Pregnancy; Reference Values; Triglycerides | 2007 |
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
Topics: Adiposity; Blood Glucose; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Fibrinolysis; Glycated Hemoglobin; Homeostasis; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1 | 2006 |
Computed tomography scans of intra-abdominal fat, anthropometric measurements, and 3 nonobese metabolic risk factors.
Topics: Abdominal Fat; Adult; Anthropometry; Blood Glucose; Blood Pressure; Body Mass Index; Case-Control Studies; Denmark; Female; Fibrinogen; Humans; Male; Metabolic Syndrome; Plasminogen Activator Inhibitor 1; Risk Factors; ROC Curve; Tomography, X-Ray Computed; Triglycerides; Waist-Hip Ratio | 2006 |
Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis.
Topics: Aged; Biomarkers; C-Reactive Protein; Calcinosis; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Female; Fibrinogen; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Uric Acid | 2007 |
Lack of synergistic effects of metabolic syndrome and plasma fibrinogen on coronary events and mortality in moderate CKD.
Topics: Chronic Disease; Cohort Studies; Coronary Artery Disease; Female; Fibrinogen; Humans; Inflammation; Kidney Diseases; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Regression Analysis | 2007 |
Venous thromboembolism--a manifestation of the metabolic syndrome.
Topics: Adult; Aged; Austria; Blood Glucose; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cytokines; Factor VIII; Female; Fibrinogen; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity; Odds Ratio; Prevalence; Prospective Studies; Pulmonary Embolism; Risk Factors; Thromboembolism; Thrombophilia; Triglycerides; Venous Thrombosis; Waist-Hip Ratio | 2007 |
Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project.
Topics: Adult; Arteries; C-Reactive Protein; Cross-Sectional Studies; Elasticity; Female; Fibrinogen; Humans; Inflammation; Insulin Resistance; Male; Metabolic Syndrome; Pulse; Risk Factors; Sex Factors | 2007 |
Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
Topics: Aged; Atherosclerosis; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Italy; Male; Metabolic Syndrome; Middle Aged; Odds Ratio; Prevalence; Risk Assessment; Risk Factors; Serum Albumin; Uric Acid | 2008 |
[Metabolic syndrome and plasma fibrinogen in type 2 diabetic patients].
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Lipids; Male; Metabolic Syndrome; Middle Aged | 2007 |
Heritability of clot formation, morphology, and lysis: the EuroCLOT study.
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Cardiovascular Diseases; Europe; Female; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Genetic Variation; Humans; Male; Metabolic Syndrome; Middle Aged; Nephelometry and Turbidimetry; Pedigree; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis; Time Factors | 2007 |
The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; E-Selectin; Female; Fibrinogen; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Phenotype; Plasminogen Activator Inhibitor 1; Thrombomodulin; Tissue Plasminogen Activator; Tunica Intima; Tunica Media; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 2008 |
Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk.
Topics: Adult; Aged; Atherosclerosis; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Insulin Resistance; Intercellular Adhesion Molecule-1; Male; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Vascular Cell Adhesion Molecule-1 | 2009 |
Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome.
Topics: Adipose Tissue; Adult; Body Composition; Body Constitution; Body Mass Index; Cross-Sectional Studies; Fibrinogen; Humans; Leukocyte Count; Logistic Models; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Obesity; Odds Ratio; Physical Fitness; Uric Acid | 2002 |